These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18700542)

  • 21. [Hypertension in the elderly].
    Plouin PF; Rossignol P; Bobrie G
    Bull Acad Natl Med; 2006; 190(4-5):793-805; discussion 806, 873-6. PubMed ID: 17195607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of optic fundus examination with retinography in initial evaluation of hypertensive patients.
    Foguet Q; Rodríguez A; Saez M; Ubieto A; Beltrán M; Barceló MA; Coll G;
    Am J Hypertens; 2008 Apr; 21(4):400-5. PubMed ID: 18369359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New ESH/ESC guidelines signal progress in hypertension management.
    Hedner T T; Narkiewicz K; Kjeldsen SE; Oparil S; ;
    Blood Press; 2007; 16(3):132-4. PubMed ID: 17846924
    [No Abstract]   [Full Text] [Related]  

  • 24. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total cardiovascular risk: a new treatment concept.
    Mancia G
    J Hypertens Suppl; 2006 Apr; 24(2):S17-24. PubMed ID: 16601556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of mild hypertension on the risks of cardiovascular disease: the Hisayama Study].
    Arima H; Kiyohara Y
    Nihon Rinsho; 2008 Aug; 66(8):1453-7. PubMed ID: 18700541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology and risk of hypertension in the elderly: the Framingham Study.
    Vokonas PS; Kannel WB; Cupples LA
    J Hypertens Suppl; 1988 Nov; 6(1):S3-9. PubMed ID: 3216240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blood pressure parameters and cardiovascular risk in the elderly].
    Blacher J; Henry O; Girerd X; Safar M
    Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):489-93. PubMed ID: 12555371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment and blood pressure control in isolated systolic hypertension vs diastolic hypertension in primary care.
    Fagard RH; Van den Enden M
    J Hum Hypertens; 2003 Oct; 17(10):681-7. PubMed ID: 14504626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilization of guidelines for the management of hypertension in cardiovascular risk scoring of renal patients.
    Mazzaferro S; Barresi G; Baldinelli M; Malagnino E; Matera G; Otranto G; Pasquali M; Pugliese F
    Clin Ter; 2006; 157(4):327-32. PubMed ID: 17051969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [ESH/ESC 2003].
    Umemura S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():562-8. PubMed ID: 16981591
    [No Abstract]   [Full Text] [Related]  

  • 33. Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect.
    Hernández-delRey R; Armario P; Martin-Baranera M; Sánchez P; Cárdenas G; Pardell H
    Blood Press Monit; 1998; 3(6):331-7. PubMed ID: 10212374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of systolic blood pressure on cardiovascular prognosis.
    Birkenhäger WH; de Leeuw PW
    J Hypertens Suppl; 1988 Nov; 6(1):S21-4. PubMed ID: 3063789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with control of blood pressure among elderly people diagnosed with hypertension in a rural area of South Korea: the Chungju Metabolic Disease Cohort Study (CMC study).
    Lee HS; Park YM; Kwon HS; Lee JH; Yoon KH; Son HY; Kim DS; Yim HW; Lee WC
    Blood Press; 2010 Feb; 19(1):31-9. PubMed ID: 19929285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal.
    Zanchetti A; Grassi G; Mancia G
    J Hypertens; 2009 May; 27(5):923-34. PubMed ID: 19381107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antihypertensive therapy according to the ESH/ESC guidelines].
    Waeber B; Feihl F
    Rev Med Suisse; 2007 Sep; 3(124):2003-4, 2006. PubMed ID: 17955827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Blood pressure control in eldery hypertension].
    Shimamoto K
    Nihon Rinsho; 2006 Jan; 64(1):75-80. PubMed ID: 16408451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High systolic blood pressure increases the risk of obtaining a disability pension because of cardiovascular disease: a cohort study of 903 174 Swedish men.
    Kark M; Rasmussen F
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):597-602. PubMed ID: 19738474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stroke risk in systolic and combined systolic and diastolic hypertension determined using ambulatory blood pressure. The Ohasama study.
    Inoue R; Ohkubo T; Kikuya M; Metoki H; Asayama K; Obara T; Hirose T; Hara A; Hoshi H; Hashimoto J; Totsune K; Satoh H; Kondo Y; Imai Y
    Am J Hypertens; 2007 Oct; 20(10):1125-31. PubMed ID: 17903698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.